Researchers conducted a genetic study to understand a condition called hereditary spastic paraplegia (HSP) in Central China. They looked at 63 unrelated families where HSP was present. Using a detailed genetic test called whole exome sequencing, they screened for changes in a specific gene called SPAST, which is known to cause a form of HSP called SPG4.
The study found that changes in the SPAST gene were present in about one-third (21 out of 63) of the families. The researchers identified seven new, previously unreported genetic changes in the SPAST gene. They also found that the average age when symptoms started was around 34 years old. In two patients, the condition presented with additional, more complex symptoms.
It is important to know this was an observational study. This means it describes what was found in this specific group of families, but it does not test a treatment or prove what causes the disease. The newly discovered genetic changes need further scientific validation to confirm their role. One of the complex symptoms, a reduced sense of smell, was seen in only a single patient, so it is too early to say if it is a common feature of SPG4.
For families affected by HSP, this study provides useful information about the genetic landscape in a specific region of China. It highlights that testing for SPAST gene changes, including deletions, is important for diagnosis. The findings add to the global understanding of SPG4 but are a step in ongoing research, not a final answer.
